Waterfront Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Buy
3,772
+52
+1% +$25K 0.31% 96
2026
Q1
$1.83M Buy
3,720
+161
+5% +$87.4K 0.34% 94
2025
Q4
$2.24M Buy
3,559
+11
+0.3% +$6.22K 0.42% 71
2025
Q3
$2M Buy
3,548
+591
+20% +$275K 0.41% 71
2025
Q2
$1.2M Buy
2,957
+19
+0.6% +$7.94K 0.27% 111
2025
Q1
$1.46M Sell
2,938
-9
-0.3% -$4.87K 0.36% 79
2024
Q4
$1.53M Buy
2,947
+1,031
+54% +$567K 0.37% 78
2024
Q3
$1.06M Buy
1,916
+159
+9% +$94.1K 0.26% 123
2024
Q2
$972K Buy
1,757
+38
+2% +$21.8K 0.26% 122
2024
Q1
$978K Buy
1,719
+42
+3% +$23.6K 0.27% 111
2023
Q4
$890K Buy
1,677
+265
+19% +$128K 0.26% 119
2023
Q3
$656K Buy
+1,412
New +$752K 0.21% 139

Other funds holding TMO

Waterfront Wealth's TMO Position: Q2 2026 in Review

Waterfront Wealth increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $25K and bringing the position to 3,772 shares worth $1.99M. The position accounts for 0.31% of the portfolio, ranked #96.

Waterfront Wealth first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.24M in Q4 2025. 1,092 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Waterfront Wealth held 3,772 shares of Thermo Fisher Scientific worth $1.99M as of Q2 2026.
  • Waterfront Wealth bought 52 Thermo Fisher Scientific shares in Q2 2026, an estimated $25K.
  • Thermo Fisher Scientific made up 0.31% of Waterfront Wealth's portfolio in Q2 2026, its #96 holding.
  • Waterfront Wealth first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Waterfront Wealth's Thermo Fisher Scientific position peaked at $2.24M in Q4 2025.
  • 1,092 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.